By DAN GOLDBERG 4:00 a.m. | Feb. 9, 2016
The number of New York City residents newly diagnosed with chronic hepatitis C increased to 7,691 in 2014, a 13 percent jump from 2013 and the most new cases the city has seen since 2011.
An estimated 146,000 New Yorkers over the age of 20 — 2.4 percent of that population — have hepatitis C, a bloodborne virus that damages the liver and is often spread among intravenous drug users, according to a new report from the city's health department which provides fresh evidence that state spending on wonder drugs such as Sovaldi and Harvoni is likely to continue to swell in the coming years.
No comments:
Post a Comment